Companies have to constantly adopt and adjust themselves to the changing market requirements, changing customer needs and expectations, new technologies and the changing environment. In the pharmaceutical market the patent protection of innovations expire after an average time of ten years – therefore research-oriented companies have to re-invent themselves every ten years accordingly. New products, manufacturing technologies and healthcare solutions represent the core of any innovation strategy. Or expressed in a different way – if companies fail to constantly re-invent themselves, they might lose their market position, customer base, or even disappear as entity. Today, General Electric is the only company remaining as such in the Dow Jones Industrial Index since it was first published in 1896.
OUR CONSULTING APPROACH BUILDS AND INTEGRATES THE CORE OF YOUR BRAND IDENTITY AND ENTERPRISE VISION AND VALUES.
THE KEY SUCCESS FACTORS ARE:
- A unique and clear vision
- The right core competencies & “know how”
- Excellent and motivated employees
- Stringent, lean processes and the will and the discipline to transform these into business results.
EXAMPLES OF SUCCESSFUL STRATEGY PROJECTS:
- Contracting strategies for Biosimilars
- ‚End of patent‘ strategies for antidepressants
- Contracting strategies in the osteoporosis market
- Market entry of OTC-products
- Positioning of new products in ophthalmology
- Strategic Market Access for diagnostic tests in oncology
- Contracting strategies for medical devices (diagnostic test)
- Positioning of HTA in the European regulatory environment
The word strategy derives from the Greek (strategia) and means ‘office of general, command, generalship’. In ancient Greece this was a leader or commander of an army. In general a strategy is a long-term plan of actions designed to achieve a particular goal, as compared to short-term tactics as parts of the overall strategy.